Table 1.
Other ENT symptom | No. of studies | DOR (95% CI)/I2 (%) | Sensitivity (95% CI)/I2 (%) | Specificity (95% CI)/I2 (%) | AUC | NPV (95% CI)/I2 (%) | PPV (95% CI)/I2 (%) |
---|---|---|---|---|---|---|---|
Nasal discharge | 14 | 1.02 (0.60–1.74)/86.8 | 0.18 (0.10–0.31)/96.1 | 0.81 (0.69–0.89)/99.0 | 0.46 | 0.75 (0.59–0.87)/99.0 | 0.21 (0.08–0.44)/98.2 |
Nasal obstruction | 8 | 0.98 (0.76–1.26)/0.0 | 0.20 (0.11–0.35)/92.7 | 0.75 (0.65–0.83)/92.0 | 0.55 | 0.62 (0.39–0.81)/98.1 | 0.31 (0.12–0.60)/96.3 |
Sore throat | 16 | 0.66 (0.38–1.15)/91.0 | 0.24 (0.16–0.33)/91.2 | 0.68 (0.58–0.77)/98.3 | 0.41 | 0.73 (0.56–0.86)/98.9 | 0.18 (0.09–0.33)/97.5 |
DOR, diagnostic odds ratio; CI, confidence interval; AUC, area under the curve; NPV, negative predictive value; PPV, positive predictive value.